Jeffrey Berkowitz

CEO
Real Endpoints

Jeff Berkowitz is one of the rare executives whose career has spanned most key verticals in the global healthcare supply chain with executive committee and other senior roles at UnitedHealth Group, Walgreens Boots Alliance and Merck.

Jeff is currently the CEO of Real Endpoints, a leader in providing insights, support and tools to strengthen access to pharmaceutical innovation for an evolving healthcare landscape with a concentrated focus on value based arrangements, patient services and market access support for pharmaceutical manufacturers and payors.

Jeff also serves as a Senior Advisor to private equity firm, Permira.

Prior to Real Endpoints, Jeff served as an Executive Vice President of UnitedHealth Group/Optum where he led Optum’s London-based International division, as CEO while also driving key strategic initiatives within Optum’s pharmacy benefits management division, OptumRx.

Prior to joining UnitedHealth Group/Optum, Jeff was a member of the Executive Committee of the Walgreens Boots Alliance where he served as President of Pharma and Global Market Access. Jeff also led Walgreens specialty pharmacy business with over $10 billion in revenue and 5,800 employees.

Before joining Walgreens, Jeff was senior vice president of global market access for Merck & Company, Inc.

Jeff began his career as a health care attorney for the international law firm Proskauer Rose LLP in New York

Berkowitz serves on the board of directors of several publicly traded healthcare companies including Lundbeck A/S, and Zealand Pharmaceuticals and previously served on the boards of Esperion Therapeutics, Uniphar and Infinity Pharmaceuticals. Berkowitz also serves on the Editorial Advisory Boards of Life Science Leader and Pharmaceutical Commerce magazines.